Pricing

Durect Corp (DRRX)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
James E. Brown
Employees:
80
10240 BUBB ROAD, CUPERTINO, CA, 95014
4087771417
Stock Split History
DateRatio
2022-12-06 1:10
DURECT Corporation researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metaboli® stress and inflammatory responses.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available